Microangiopathic hemolytic anemia
{{{Name|Microangiopathic hemolytic anemia}}}
[[Image:{{{Image}}}|190px|center|]] {{{Caption|}}}
|
| ICD-10
| D59.4
|
| ICD-O:
| {{{ICDO}}}
|
| ICD-9
|
|
| OMIM
| }}}
|
| MedlinePlus
| }}}
|
| eMedicine
| }}}
|
| DiseasesDB
| }}}
|
In medicine(hematology) microangiopathic hemolytic anemia (MAHA) is a subgroup of hemolytic anemia(anemia, loss of red blood cells through destruction) caused by factors in the small blood vessels. It is identified by the finding of anemia and schistocytes("bite cells") on microscopyof the blood film.
Automated analysers(the machines that perform routine full blood countsin most hospitals) are generally programmed to flag blood films that display red blood cell fragments or schistocytes.
The most important causes are:
- Thrombotic thrombocytopenic purpura(TTP)
- Hemolytic uremic syndrome(HUS)
- Disseminated intravascular coagulation(DIC)
- HELLP syndromeand eclampsia
- Heparin-induced thrombocytopenia(HIT)
- Severe glomerulonephritis
- Several other rare causes
In all causes, the mechanism of MAHA is the formation of a fibrinmesh due to increased activity of the system of coagulation. The red blood cells are physically cut by these protein networks, and the fragments are identical to the schistocytes seen on light microscopy.
Categories: Medicine stubs| Hematology| Nephrology
This article is licensed under the GNU Free Documentation License. It uses material from the http://en.wikipedia.org/wiki/Microangiopathic+hemolytic+anemia Wikipedia article Microangiopathic hemolytic anemia.
|